Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Reignier

Showing results (181-190 of 220) with videos related to

Pageof 22
Sort By:
JAMA|October 26, 2018
Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical TrialElie Azoulay, Virginie Lemiale, Djamel Mokart, et al.
The New England Journal of Medicine|October 26, 2022
Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-PieceArnaud W Thille, Arnaud Gacouin, Rémi Coudroy, et al.
Trials|March 7, 2018
High-flow nasal oxygen vs. standard oxygen therapy in immunocompromised patients with acute respiratory failure: study protocol for a randomized controlled trialElie Azoulay, Virginie Lemiale, Djamel Mokart, et al.
JAMA|October 8, 2015
Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical TrialVirginie Lemiale, Djamel Mokart, Matthieu Resche-Rigon, et al.
BMJ Open|February 13, 2021
Comparison of high-flow nasal oxygen therapy and non-invasive ventilation in ICU patients with acute respiratory failure and a do-not-intubate orders: a multicentre prospective study OXYPALRené Robert, Denis Frasca, Julie Badin, et al.
BMJ Open|October 24, 2024
Effect of high-flow nasal cannula oxygen versus standard oxygen on mortality in patients with acute hypoxaemic respiratory failure: protocol for a multicentre, randomised controlled trial (SOHO)Jean-Pierre Frat, Remi Coudroy, Jean-Pierre Quenot, et al.
The Lancet. Respiratory Medicine|November 14, 2021
Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trialAurélien Mazeraud, Matthieu Jamme, Rossella Letizia Mancusi, et al.
BMJ Open|November 25, 2020
T-piece versus pressure-support ventilation for spontaneous breathing trials before extubation in patients at high risk of reintubation: protocol for a multicentre, randomised controlled trial (TIP-EX)Arnaud W Thille, Rémi Coudroy, Arnaud Gacouin, et al.
JAMA|October 29, 2025
Sodium Bicarbonate for Severe Metabolic Acidemia and Acute Kidney Injury: The BICARICU-2 Randomized Clinical TrialBoris Jung, Mathieu Jabaudon, Audrey De Jong, et al.
Respiratory Research|March 5, 2025
Early bacterial co-infections and ventilator-associated lower respiratory tract infections among intubated patients during the first and second COVID-19 waves: a European comparative cohort studyAnahita Rouze, Pedro Povoa, Ignacio Martin-Loeches, et al.
Pageof 22

Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
JAMA|October 26, 2018
Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical TrialElie Azoulay, Virginie Lemiale, Djamel Mokart, et al.
The New England Journal of Medicine|October 26, 2022
Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-PieceArnaud W Thille, Arnaud Gacouin, Rémi Coudroy, et al.
Trials|March 7, 2018
High-flow nasal oxygen vs. standard oxygen therapy in immunocompromised patients with acute respiratory failure: study protocol for a randomized controlled trialElie Azoulay, Virginie Lemiale, Djamel Mokart, et al.
JAMA|October 8, 2015
Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical TrialVirginie Lemiale, Djamel Mokart, Matthieu Resche-Rigon, et al.
BMJ Open|February 13, 2021
Comparison of high-flow nasal oxygen therapy and non-invasive ventilation in ICU patients with acute respiratory failure and a do-not-intubate orders: a multicentre prospective study OXYPALRené Robert, Denis Frasca, Julie Badin, et al.
BMJ Open|October 24, 2024
Effect of high-flow nasal cannula oxygen versus standard oxygen on mortality in patients with acute hypoxaemic respiratory failure: protocol for a multicentre, randomised controlled trial (SOHO)Jean-Pierre Frat, Remi Coudroy, Jean-Pierre Quenot, et al.
The Lancet. Respiratory Medicine|November 14, 2021
Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trialAurélien Mazeraud, Matthieu Jamme, Rossella Letizia Mancusi, et al.
BMJ Open|November 25, 2020
T-piece versus pressure-support ventilation for spontaneous breathing trials before extubation in patients at high risk of reintubation: protocol for a multicentre, randomised controlled trial (TIP-EX)Arnaud W Thille, Rémi Coudroy, Arnaud Gacouin, et al.
JAMA|October 29, 2025
Sodium Bicarbonate for Severe Metabolic Acidemia and Acute Kidney Injury: The BICARICU-2 Randomized Clinical TrialBoris Jung, Mathieu Jabaudon, Audrey De Jong, et al.
Respiratory Research|March 5, 2025
Early bacterial co-infections and ventilator-associated lower respiratory tract infections among intubated patients during the first and second COVID-19 waves: a European comparative cohort studyAnahita Rouze, Pedro Povoa, Ignacio Martin-Loeches, et al.
Pageof 22